KOL Insights on the ADA Scientific Session Featuring Matthias H. Tschöp, MD

As a part of HealthDay’s conference coverage, Dr. Matthias Tschöp joins us to share exciting research on the drug Tirzepatide discussed at this year’s American Diabetes Association’s Scientific Session.

KOL Insights on the ADA Scientific Session Featuring Matthias H. Tschöp, MD
HealthDay


Read this Next
About UsOur ProductsCustom SolutionsHow it’s SoldOur ResultsDeliveryContact UsBlogPrivacy PolicyFAQ